Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
30 hedge funds and large institutions have $348M invested in Myovant Sciences Ltd. in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 9 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
14% less funds holding
Funds holding: 35 → 30 (-5)
29% less capital invested
Capital invested by funds: $490M → $348M (-$142M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
NovaQuest Capital Management
Raleigh,
North Carolina
|
+$45.1M |
| 2 |
Bank of New York Mellon
New York
|
+$7.05M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$5.12M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$1.77M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$792K |
| 3 |
Morgan Stanley
New York
|
-$766K |
| 4 |
State Street
Boston,
Massachusetts
|
-$640K |
| 5 |
MC
Matisse Capital
Portland,
Oregon
|
-$405K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Legal & General Group
London,
United Kingdom
| $9K | +$10.5K | +533 | New |
|
27
Bank of America
Charlotte,
North Carolina
| $4K | +$2.9K | +147 | +152% |
|
28
Macquarie Group
Sydney, NSW 2000,
Australia
| $3K | -$493 | -25 | -13% |
|
29
BNP Paribas Financial Markets
Paris,
France
| $1K | -$769 | -39 | -39% |
|
30
Citigroup
New York
| $1K | +$1K | +51 | +340% |
|
|
31
Northern Trust
Chicago,
Illinois
| – | -$792K | -29,847 | Closed |
|
|
MC
32
Matisse Capital
Portland,
Oregon
| – | -$405K | -15,250 | Closed |
|
|
WAM
33
Weiss Asset Management
Boston,
Massachusetts
| – | -$254K | -9,552 | Closed |
|
34
Two Sigma Investments
New York
| – | -$202K | -7,593 | Closed |
|
|
AI
35
Atria Investments
Charlotte,
North Carolina
| – | -$201K | -7,581 | Closed |
|
|
OTC
36
Opera Trading Capital
Paris,
France
| – | -$117K | -4,417 | Closed |
|
|
PCM
37
Prelude Capital Management
New York
| – | -$101K | -3,818 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$66K | -2,500 | Closed |
|
|
SBL
39
Sargent Bickham Lagudis
Boulder,
Colorado
| – | -$6K | -215 | Closed |
|
MYOV Hedge Fund Activity: Q4 2018 in Review
30 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2018, worth a combined $348M — down 29% from $490M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MYOV and 4 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 16 added.
The largest buyer was NovaQuest Capital Management, adding an estimated $45.1M. The largest seller was Millennium Management, cutting an estimated $7M.
- 30 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2018, down from 35 in Q3 2018.
- Funds reported $348M of Myovant Sciences Ltd. stock for Q4 2018, down 29% quarter-over-quarter.
- 4 funds opened new Myovant Sciences Ltd. positions in Q4 2018 and 9 closed out, a net change of -5 holders.
- The largest Myovant Sciences Ltd. buyer in Q4 2018 was NovaQuest Capital Management, an estimated $45.1M added.
- The largest Myovant Sciences Ltd. seller in Q4 2018 was Millennium Management, an estimated $7M sold.
Based on aggregated 13F filings for Q4 2018.